Synthetic Biology
FTO Inhibitors

FTO Inhibitors

Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / FTO Inhibitors /

FTO Inhibitors

FTO inhibitors are a class of pharmaceutical compounds that have shown promise in the field of obesity and metabolic disorders FTO or Fat Mass and Obesity-associated protein has been identified as a key regulator of energy metabolism and body weight By inhibiting the activity of FTO these inhibitors have the potential to modulate energy homeostasis and offer a novel approach to managing conditions related to excess weight gain With mounting evidence supporting their efficacy FTO inhibitors may represent a promising therapeutic avenue for addressing the global obesity epidemic and improving overall health outcomes

Catalog Number Chemical Name CAS # Price
BC-0448 Radicicol 12772-57-5 Online Inquiry
BC-0564 Entacapone 130929-57-6 Online Inquiry
EI-0399 Bisantrene dihydrochloride 78186-34-2 Online Inquiry
EI-0457 Brequinar Sodium 96201-88-6 Online Inquiry
EI-0972 FB23-2 2243736-45-8 Online Inquiry
EI-1430 Meclofenamic acid sodium salt 6385-02-0 Online Inquiry
EI-1881 Rhein 478-43-3 Online Inquiry

Application

FTO inhibitors are a crucial tool in the field of obesity and metabolic research These inhibitors specifically target the FTO enzyme which is known to play a role in regulating energy balance and body weight By inhibiting FTO activity researchers can gain a deeper understanding of how this enzyme contributes to obesity and can potentially develop new therapeutic strategies for managing weight loss and improving metabolic health

In addition to their role in obesity research FTO inhibitors also hold promise in the field of cancer Studies have shown that FTO overexpression is associated with various types of cancer including leukemia and breast cancer By inhibiting FTO researchers hope to disrupt the cancer-promoting effects of this enzyme and potentially develop new targeted therapies for cancer treatment

Furthermore FTO inhibitors have implications in the field of neurodegenerative disorders such as Alzheimer's disease Research has shown that FTO plays a role in regulating cognitive function and neuronal health By inhibiting FTO scientists aim to explore the potential therapeutic benefits of targeting this enzyme in preventing or slowing down the progression of neurodegenerative diseases

Overall FTO inhibitors have a wide range of applications in biomedical research including obesity cancer and neurodegenerative disorders These inhibitors offer exciting opportunities for understanding disease mechanisms and developing innovative treatments and interventions

Please note that all services are for research use only. Not intended for any clinical use.

Synthetic Biology Products

Online Inquiry